Gallium-68 PSMA PET-CT
in Turkey

Discover Gallium-68 PSMA PET-CT
in Turkey

Prostate cancer is one of the most prevalent cancers among men worldwide, making early detection and accurate diagnosis crucial for effective treatment. Fortunately, advancements in medical imaging have revolutionized the way healthcare professionals diagnose and manage this disease. One such breakthrough is the Gallium-68 PSMA PET-CT scan, a cutting-edge imaging technique that offers unprecedented precision in detecting prostate cancer cells. 

What is Gallium-68 PSMA PET-CT?

Gallium-68 PSMA PET-CT, also known as Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography, is an advanced imaging modality specifically designed for prostate cancer evaluation. It combines two powerful imaging techniques: PET (Positron Emission Tomography) and CT (Computed Tomography). The PET scan uses a radioactive tracer called Gallium-68 PSMA, which targets prostate-specific membrane antigen (PSMA) receptors found on the surface of prostate cancer cells. This allows for highly sensitive and precise detection of cancerous lesions throughout the body.

How does it work?

During a Gallium-68 PSMA PET-CT scan, the patient is injected with the Gallium-68 PSMA tracer, which circulates throughout the body and binds to PSMA receptors on prostate cancer cells. The PET scanner detects the gamma rays emitted by the tracer, creating detailed images that highlight areas of increased PSMA activity, indicative of cancerous tissue. Simultaneously, the CT scan provides anatomical context, helping to pinpoint the exact location of abnormal findings and assess their size and extent.

What are the benefits
of Gallium-68 PSMA PET-CT?

  1. Improved Detection: Gallium-68 PSMA PET-CT offers superior sensitivity and specificity compared to conventional imaging modalities, such as CT or bone scans. It can detect small lesions and metastases that may be missed by other methods, allowing for more accurate staging of the disease.
  2. Personalized Treatment Planning: By accurately identifying the extent and location of prostate cancer lesions, Gallium-68 PSMA PET-CT enables healthcare providers to tailor treatment plans to individual patients. This may include decisions regarding surgery, radiation therapy, chemotherapy, or other targeted therapies.
  3. Early Detection of Recurrence: In patients with recurrent prostate cancer, Gallium-68 PSMA PET-CT can detect disease recurrence at earlier stages than conventional imaging techniques. This early detection allows for prompt intervention and may improve outcomes.
  4. Reduced Need for Invasive Procedures: Gallium-68 PSMA PET-CT can help reduce the need for invasive procedures, such as biopsies or exploratory surgery, by providing comprehensive information about the extent and location of prostate cancer lesions.

Is Gallium-68 PSMA PET-CT safe?

Like any medical procedure involving radiation, Gallium-68 PSMA PET-CT carries some risks, though they are minimal. The amount of radiation exposure from the Gallium-68 tracer is relatively low, and the benefits of accurate cancer detection typically outweigh the risks. However, patients should discuss any concerns with their healthcare provider before undergoing the procedure.

Gallium-68 PSMA PET-CT represents a significant advancement in the diagnosis and management of prostate cancer, offering unprecedented accuracy in detecting cancerous lesions throughout the body. By harnessing the power of molecular imaging, this innovative technique provides valuable information that can guide personalized treatment decisions and improve patient outcomes. As research continues to refine and expand the utility of Gallium-68 PSMA PET-CT, its role in prostate cancer care is expected to grow, offering hope for more effective and targeted therapies in the fight against this prevalent disease.

You can contact us 24/7.
0850 241 3311

Follow us on